Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Basal insulins.

Pablo F Mora1

  • 1Dallas Diabetes Research Center at Medical City, Associate Professor at University of Texas, Southwestern Medical Center, Dallas, TX, USA.

The Journal of Family Practice
|October 10, 2017
PubMed
Summary

Achieving consistent 24-hour basal insulin delivery for metabolic needs is challenging. The subcutaneous route, while practical, is physiologically unnatural for mimicking the body's precise insulin release patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes.

BMJ open diabetes research & care·2020
Same author

EFFICACY AND SAFETY OF IGLARLIXI IN HISPANICS AND NON-HISPANIC WHITES WITH TYPE 2 DIABETES.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2019
Same author

CARDIOVASCULAR OUTCOME TRIALS OF THE INCRETIN-BASED THERAPIES: WHAT DO WE KNOW SO FAR?

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2016
Same author

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2012
Same author

New-onset diabetes after renal transplantation.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2010
Same author

Insulin therapy in type 2 diabetes.

Endocrine research·2007

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Healthy humans exhibit precise insulin release tied to metabolic demands, including basal and burst secretions.
  • Two main insulin formulations exist: basal for continuous needs and prandial for post-meal glucose spikes.

Purpose of the Study:

  • To discuss the challenges in developing basal insulin formulations that mimic physiologic insulin release.
  • To highlight the limitations of the subcutaneous route for achieving constant, natural insulin effect.

Main Methods:

  • Review of insulin physiology and formulation development.
  • Analysis of the practicalities and physiological limitations of subcutaneous insulin administration.

Main Results:

  • Mimicking the body's dynamic insulin secretion with basal formulations is complex.

Related Experiment Videos

  • The subcutaneous route presents inherent challenges for achieving a constant, physiologically accurate basal insulin effect over 24 hours.

    • Conclusions:

    • Developing ideal basal insulin requires overcoming the physiological mismatch of subcutaneous delivery.
    • Further innovation is needed to better approximate natural insulin profiles for metabolic control.